These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2167799

  • 1. Glycosaminoglycan content, oxalate self-exchange and protein phosphorylation in erythrocytes of patients with 'idiopathic' calcium oxalate nephrolithiasis.
    Baggio B, Marzaro G, Gambaro G, Marchini F, Williams HE, Borsatti A.
    Clin Sci (Lond); 1990 Aug; 79(2):113-6. PubMed ID: 2167799
    [Abstract] [Full Text] [Related]

  • 2. Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis.
    Baggio B, Bordin L, Gambaro G, Piccoli A, Marzaro G, Clari G.
    Miner Electrolyte Metab; 1993 Aug; 19(1):17-20. PubMed ID: 8393959
    [Abstract] [Full Text] [Related]

  • 3. [Abnormalities in the erythrocyte membrane transport of oxalate in calcium oxalate lithogenesis].
    Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A.
    Nephrologie; 1984 Aug; 5(4):173-4. PubMed ID: 6527719
    [Abstract] [Full Text] [Related]

  • 4. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G, Petrarulo M, Nardelotto A, Marangella M, Baggio B.
    Kidney Int; 1995 Nov; 48(5):1549-52. PubMed ID: 8544412
    [Abstract] [Full Text] [Related]

  • 5. Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis.
    Baggio B, Gambaro G, Marzaro G, Marchini F, Borsatti A, Crepaldi G.
    Eur J Clin Pharmacol; 1991 Nov; 40(3):237-40. PubMed ID: 2060558
    [Abstract] [Full Text] [Related]

  • 6. Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A.
    Lancet; 1984 Jul 07; 2(8393):12-3. PubMed ID: 6145933
    [Abstract] [Full Text] [Related]

  • 7. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans.
    Baggio B, Gambaro G, Marchini F, Marzaro G, Williams HE, Borsatti A.
    Lancet; 1991 Aug 17; 338(8764):403-5. PubMed ID: 1678082
    [Abstract] [Full Text] [Related]

  • 8. Idiopathic calcium oxalate nephrolithiasis: a cellular disease.
    Gambaro G, Baggio B.
    Scanning Microsc; 1992 Mar 17; 6(1):247-54. PubMed ID: 1626244
    [Abstract] [Full Text] [Related]

  • 9. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis.
    Baggio B, Gambaro G, Zambon S, Marchini F, Bassi A, Bordin L, Clari G, Manzato E.
    J Am Soc Nephrol; 1996 Apr 17; 7(4):613-20. PubMed ID: 8724896
    [Abstract] [Full Text] [Related]

  • 10. Abnormal urate transport in erythrocytes of patients with idiopathic calcium nephrolithiasis: a possible link with hyperuricosuria.
    Gambaro G, Vincenti M, Marchini F, D'Angelo A, Baggio B.
    Clin Sci (Lond); 1993 Jul 17; 85(1):41-4. PubMed ID: 8149692
    [Abstract] [Full Text] [Related]

  • 11. Red blood cell transmembrane oxalate flux in calcium-oxalate nephrolithiasis.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A.
    Contrib Nephrol; 1985 Jul 17; 49():118-21. PubMed ID: 3830561
    [No Abstract] [Full Text] [Related]

  • 12. Relation between band 3 red blood cell protein and transmembrane oxalate flux in stone formers.
    Baggio B, Gambaro G, Borsatti A, Clari G, Moret V.
    Lancet; 1984 Jul 28; 2(8396):223-4. PubMed ID: 6146776
    [No Abstract] [Full Text] [Related]

  • 13. Transmembrane oxalate exchange: its relationship to idiopathic calcium oxalate nephrolithiasis.
    Motola JA, Urivetsky M, Molia L, Smith AD.
    J Urol; 1992 Mar 28; 147(3):549-52. PubMed ID: 1538426
    [Abstract] [Full Text] [Related]

  • 14. The abnormal red-cell oxalate transport is a risk factor for idiopathic calcium nephrolithiasis: a prospective study.
    Gambaro G, Marchini F, Piccoli A, Nassuato MA, Bilora F, Baggio B.
    J Am Soc Nephrol; 1996 Apr 28; 7(4):608-12. PubMed ID: 8724895
    [Abstract] [Full Text] [Related]

  • 15. Re: Transmembrane oxalate exchange and its relationship to idiopathic calcium oxalate nephrolithiasis.
    Gambaro G, Baggio B.
    J Urol; 1993 Apr 28; 149(4):865-6. PubMed ID: 8455260
    [No Abstract] [Full Text] [Related]

  • 16. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis.
    Baggio B, Priante G, Brunati AM, Clari G, Bordin L.
    J Am Soc Nephrol; 1999 Nov 28; 10 Suppl 14():S381-4. PubMed ID: 10541268
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M.
    Scand J Urol Nephrol Suppl; 1989 Nov 28; 119():1-53. PubMed ID: 2669121
    [Abstract] [Full Text] [Related]

  • 19. [Oxalate as a promoter in calcium oxalate nephrolithiasis].
    Yamakawa K, Katou T, Arima K, Yanagawa M, Kawamura J.
    Hinyokika Kiyo; 1991 Oct 28; 37(10):1111-4. PubMed ID: 1755400
    [Abstract] [Full Text] [Related]

  • 20. Abnormal arachidonic acid content of red blood cell membranes and main lithogenic factors in stone formers.
    Messa P, Londero D, Massarino F, Paganin L, Mioni G, Zattoni F, Cannella G.
    Nephrol Dial Transplant; 2000 Sep 28; 15(9):1388-93. PubMed ID: 10978396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.